BAVIS_1170X120_10-19-20

Erez Israeli

Dr. Reddy’s gets approval for their NDA, Elyxyb (celecoxib oral solution) 25 mg/mL, in the U.S.

Dr. Reddy’s gets approval for their NDA, Elyxyb (celecoxib oral solution) 25 mg/mL, in the U.S.

PRINCETON, N.J. —Dr. Reddy’s announced approval of Elyxyb (celecoxib oral solution 25 mg/mL) by the U.S. Food and Drug Administration (USFDA). Elyxyb (previously known as DFN-15) is indicated for the acute treatment of migraine with or without aura in adults. Elyxyb is the latest product emerging from Dr. Reddy’s portfolio of successful acute migraine treatments.